CGON Competitors & Alternatives
Compare CG Oncology, Inc. Common stock with similar stocks in the same industry
Biotechnology
CGON
Main Stock$72.35
Tradestie Score
46
Market Cap
$3.01B
Revenue Growth
19.8%
Analyst Upside
+25.9%
Top Competitors
233 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
MRUS
Merus N.V. Common Shares
|
$90.00
|
$7.14B | - | 39 | Compare |
|
CYTK
Cytokinetics Inc.
|
$73.77
|
$6.68B | - | 53 | Compare |
|
RYTM
Rhythm Pharmaceuticals, Inc. Common Stock
|
$104.71
|
$6.64B | - | 62 | Compare |
|
ABVX
Abivax SA American Depositary Shares
|
$118.64
|
$6.38B | - | 56 | Compare |
|
LEGN
Legend Biotech Corporation American Depositary Shares
|
$18.64
|
$6.03B | - | 44 | Compare |
|
CRSP
CRISPR Therapeutics AG
|
$51.72
|
$6.02B | - | 44 | Compare |
|
NUVL
Nuvalent, Inc. Class A Common Stock
|
$123.96
|
$5.95B | - | 44 | Compare |
|
AXSM
Axsome Therapeutics, Inc
|
$220.75
|
$5.92B | - | 56 | Compare |
|
TGTX
TG Therapeutics, Inc.
|
$53.89
|
$5.80B | 20.0 | 49 | Compare |
|
KRYS
Krystal Biotech, Inc. Common Stock
|
$347.00
|
$5.20B | 43.3 | 47 | Compare |
More CGON Analysis
Data updated: Sep 11, 2026 | Industry: Biotechnology (SIC 2836)
233 stocks in this industry